When was Mybacs founded?

Mybacs was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is Mybacs located?

Mybacs is headquartered in Baar, Switzerland. It is registered at Hohenzollernstr. 88, 80796 München.

Who is the current CEO of Mybacs?

Sebastian Wahl and Carl-Philipp von Polheim s of Mybacs. Sebastian Wahl has also founded 1 company.

How many employees does Mybacs have?

As of Aug 31, 2026, the latest employee count at Mybacs is 63.

Is Mybacs a funded company?

Mybacs is a funded company, having raised a total of $5.92M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 29, 2019.

When was the latest funding round of Mybacs?

Mybacs' latest funding was a $***** Series A round on Oct 30, 2023, with participation from 5 investors.

Where does Mybacs rank among its competitors?

Mybacs ranks 10th amongst 81 active competitors, of which 25 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Vizzhy, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of Mybacs?

Mybacs' top competitors include Bioniq, Zoe and OptiBiotix Health. Among them, Vizzhy secured the most recent funding round in August, 2025.

Mybacs - 2026 Company Profile, Team, Funding & Competitors

Mybacs is a series A company based in Baar (Switzerland), founded in 2018 by Adrian Weingart, Sebastian Wahl and Carl-Philipp von Polheim. It operates as a Manufacturer of probiotic products for digestion. Mybacs has raised $5.92M in funding from investors like Global Founders Capital, Joyance Partners and naturalX Health Ventures. The company has 81 active competitors, including 25 funded and 5 that have exited. Its top competitors include companies like Bioniq, Zoe and OptiBiotix Health.

Company Details

Mybacs manufactures and markets probiotic supplements for digestion. The products provided are for every day or trip. The products are a mixture of gut bacteria, vitamins, proteins, and minerals. The product can help in digestion, cardiac problem, and others.

Website: mybacs.com
Social
Email ID: *****@mybacs.co
Phone Number: +41 **********
Registered Address: Hohenzollernstr. 88, 80796 München

Key Metrics

Founded Year

2018

Location

Baar, Switzerland

Stage

Series A

Total Funding

$5.92M in 3 rounds

Latest Funding Round

Series A, Oct 30, 2023, $*****

Investors

Global Founders Capital & 8 more

Ranked

10^th among 81 active competitors

Employee Count

63 as on Aug 31, 2026

Similar Companies

Bioniq & 99 more

View Mybacs' full profile

Mybacs is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
mybacs AG CIN: 1359459 , Switzerland, Active	Mar 05, 2024	-	-	-
mybacs Vertriebs GmbH CIN: D2601_HRB245239 , Germany, Active	Dec 07, 2018	-	-

Mybacs has raised a total funding of $5.92M over 3 rounds. Its first funding round was on Aug 29, 2019. Its latest funding round was a Series A round on Oct 30, 2023 for $*****. 5 investors participated in its latest round. Mybacs has 9 institutional investors.

Here is the list of recent funding rounds of Mybacs:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 30, 2023	3549106	Series A	3742797	8845235	6735178	3888308
Jul 09, 2020	9788799	Seed	5184479	7148464	2188718	Global Founders Capital & 1 more
Aug 29, 2019	8253071	Seed	6271941	9520152	Global Founders Capital	5221756

Access funding benchmarks and valuations. Sign up today!

View details of Mybacs's funding rounds and investors

The founders of Mybacs are Adrian Weingart, Sebastian Wahl and Carl-Philipp von Polheim. Sebastian Wahl and Carl-Philipp von Polheim are the CEOs of Mybacs.

Here are the details of Mybacs' key team members:

Adrian Weingart: Co-Founder of Mybacs.
Sebastian Wahl: Co-Founder & Co-CEO of Mybacs.
Contact Info: 1 email address
Carl-Philipp von Polheim: Co-Founder & Co-CEO of Mybacs.
Contact Info: 1 email address

View details of Mybacs's Founder profiles and Board Members

Mybacs' employee count trend

Mybacs has 63 employees as of Aug 26. Here is Mybacs's employee count trend over the years:

Uncover Mybacs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Mybacs include Bioniq, Zoe and OptiBiotix Health. Here is the list of Top 10 competitors of Mybacs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bioniq 2019, London (United Kingdom), Series B	Provider of personalized nutritional supplements using patented Swiss granules	$34.2M	Unbound, HV Capital & 13 others	63/100
2nd	Zoe 2017, New Castle (United States), Late Stage	Provider of gut health testing services and plant based supplements	$133M	Balderton Capital, Ahren & 12 others	57/100
3rd	OptiBiotix Health 2012, York (United Kingdom), Public	Developer of microbial strains for the treatment of human metabolic diseases	-	Seneca EIS Portfolio Fund, Enterprise Ventures ... & 2 others	55/100
4th	Azitra 2014, Farmington (United States), Public	Developer of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema	$37.4M	Bios Partners, Connecticut Innovations & 8 others	50/100
5th	Flore 2016, San Diego (United States), Series A	Provide nutritional supplements to improve gut health	$21.1M	Pangaea Ventures, K3 & 11 others	49/100
6th	Vizzhy 2019, Austin (United States), Seed	Provider of multi omics based metabolic signature program and solutions for metabolic health issues	-	Genie Healthcare	47/100
7th	BiomeSense 2018, Chicago (United States), Seed	Developer of AI-enabled technology platform for microbiome data generation and analysis	$8.43M	Bluestein Ventures, IndieBio & 11 others	47/100
8th	Seed 2016, Los Angeles (United States), Series A	Developer of synbiotics for simulating gut microbiome	$40.6M	Greycroft, BoxGroup & 28 others	45/100
9th	uBiome 2012, San Francisco (United States), Deadpooled	Provider of sequence dataset of human microbiome	$110M	Andreessen Horowitz, Y Combinator & 26 others	45/100
10th	Mybacs 2018, Baar (Switzerland), Series A	Manufacturer of probiotic products for digestion	$5.92M	Global Founders Capital, Social Starts & 7 others	45/100